Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
29
30
Next >
How the market’s biggest companies manage their cash and investments
April 05, 2023
Tags
Money Market
Earnings
Markets
From
CNBC.com News
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
March 29, 2023
Tags
Moderna Inc
Biotechnology
US: News
From
CNBC.com News
BioNTech shares slip on gloomy Covid vaccine sales outlook
March 27, 2023
Tags
Stock markets
stocks
BioNTech SE
From
CNBC.com News
Pfizer signs agreement with China on improving health coverage in the country
March 26, 2023
Tags
stocks
Stock markets
Market Insider
From
CNBC.com News
Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says
March 24, 2023
Tags
Coronavirus
Health care industry
US: News
From
CNBC.com News
FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people
March 16, 2023
Tags
Biotechnology
Coronavirus
US: News
From
CNBC.com News
Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs
March 15, 2023
Tags
Pfizer Inc
Business News
Politics
From
CNBC.com News
FDA authorizes Pfizer's Covid omicron booster as fourth shot for kids under 5
March 14, 2023
Tags
Moderna Inc
Biotechnology
BioNTech SE
From
CNBC.com News
FDA staff report says data shows Pfizer's Covid treatment Paxlovid is effective in high-risk adults
March 14, 2023
Tags
Health care industry
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
CNBC Daily Open: Banks got hammered by SVB's collapse. But the Fed might still raise rates
March 14, 2023
Tags
Western Alliance Bancorp
Market Outlook
Goldman Sachs Group Inc
From
CNBC.com News
CNBC Daily Open: The bank rout continues. The Fed might still raise rates anyway
March 13, 2023
Tags
Citigroup Inc
Central banking
Banks
From
CNBC.com News
Pfizer CEO says it will be able to deliver Seagen's cancer therapy at a scale not seen before with $43 billion deal
March 13, 2023
Tags
Investment strategy
US: News
Markets
From
CNBC.com News
Stocks making the biggest moves premarket: Illumina, First Republic, Seagen and more
March 13, 2023
Tags
Markets
Citigroup Inc
Seagen Inc
From
CNBC.com News
China is rolling out the red carpet to attract foreign executives
March 02, 2023
Tags
Market Insider
China Economy
Asia News
From
CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
Tags
Biotechnology
Health & Science
Business
From
CNBC.com News
Cramer's lightning round: Pfizer is a buy in a market slowdown
February 21, 2023
Tags
AST SpaceMobile Inc
S&P 500
Investment Strategy
From
CNBC.com News
Pfizer RSV vaccine that protects infants could receive FDA approval this summer
February 21, 2023
Tags
Pfizer Inc
Business News
U/S/ Economy
From
CNBC.com News
Eli Lilly recruits Black patients for Alzheimer trial as drugmakers seek more diversity in clinical studies
February 16, 2023
Tags
CVS Health Corp
Eli Lilly and Co
Kroger Co
From
CNBC.com News
U.S. plans to stop buying Covid shots for the public this fall. Here's what that means
February 04, 2023
Tags
Moderna Inc
Biotechnology
Health & Science
From
CNBC.com News
The end of the Covid health emergency won't slow FDA clearance of shots and treatments
January 31, 2023
Tags
Health care industry
Politics
Policy
From
CNBC.com News
Stocks making the biggest moves premarket: McDonald's, UPS, General Motors and more
January 31, 2023
Tags
McDonald's Corp
Pfizer Inc
United Parcel Service Inc
From
CNBC.com News
Pfizer expects 2023 sales to decline by as much as 33% compared with record-breaking 2022
January 31, 2023
Tags
Biotechnology
US: News
Disease outbreaks
From
CNBC.com News
5 things to know before the stock market opens Monday, January 30
January 30, 2023
Tags
Walmart Inc
General Motors Co
Markets
From
CNBC.com News
Cramer’s week ahead: Fed decision on Wednesday could let the bulls ‘party on’
January 27, 2023
Tags
Markets
Mad Money
Ford Motor Co
From
CNBC.com News
Stocks making the biggest moves midday: Chevron, Tesla, Seagate Technology, United Rentals and more
January 26, 2023
Tags
Chevron Corp
Viasat Inc
Finance
From
CNBC.com News
FDA has not observed stroke risk among seniors who received Pfizer booster after extensive review
January 26, 2023
Tags
Politics
Policy
Health care industry
From
CNBC.com News
Stocks making the biggest moves premarket: Southwest, Tesla, Las Vegas Sands and more
January 26, 2023
Tags
Levi Strauss & Co
Breaking News: Markets
Economy
From
CNBC.com News
Omicron booster shots provide some protection against mild illness from Covid XBB subvariants, CDC says
January 25, 2023
Tags
Moderna Inc
Biotechnology
Health & Science
From
CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
January 18, 2023
Tags
CNBC Disruptor 50
Vaccinations
Respiratory syncytial virus
From
CNBC.com News
Cramer's lightning round: I think Boeing is good
January 17, 2023
Tags
Pfizer Inc
Business News
S&P 500
From
CNBC.com News
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.